High-Density Lipoproteins and Their Role in Preventing or Retarding Atherosclerosis

  • Gerd Assmann
  • Hilko Schriewer

Abstract

Among the primary risk factors of coronary heart disease (CHD), hypercholesterolemia, hypertension, and nicotine abuse take highest precedence. A total cholesterol level > 300 mg/dl signifies a high atherogenic risk for the person in question. However, hypercholesterolemia (> 300 mg/dl) is observed in only approximately 25% of all patients with CHD. The majority of CHD patients exhibit a total cholesterol level between 248 and 300 mg/dl. In correspondence with the results of the Framingham study, the distribution curve for total serum cholesterol in probands in whom CHD develops overlaps considerably with that in probands who exhibit no CHD; the average cholesterol value of probands suffering from CHD is 225 mg/dl (219 mg/dl in probands in whom CHD does not develop).1 With these results as a basis, it is not possible, in an individual case involving a total cholesterol level between 150 and 300 mg/dl, to make a statement regarding coronary risk.

Keywords

Cholesteryl Ester Total Cholesterol Level Coronary Risk Framingham Study Coronary Heart Disease Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    W. B. Kannel, W. P. Castelli and T. Gordon, Cholesterol in the prediction of atherosclerotic disease. New perspective based on Framingham study, Ann. Intern. Med. 90: 85 (1979).CrossRefGoogle Scholar
  2. 2.
    G. Assmann, “Lipid Metabolism and Atherosclerosis,” Schattauer-Verlag, Stuttgart (1982).Google Scholar
  3. 3.
    G. Assmann, H. Schriewer, and K. H. Juchem, Zur Rolle des HDL-Cholesterins in der Präventivmedizin, Therapiewoch 31: 5563 (1981).Google Scholar
  4. 4.
    R. W. Mahley, Alterations in plasma lipoproteins induced by cholesterol feeding in animals including man, in: “Disturbances in Lipid and Lipoprotein Metabolism,” J. M. Dietschy, A. M. Gotto Jr., and J, A. Ontko, eds., American Physiological Society, Bethesda (USA) (1978).Google Scholar
  5. 5.
    W. Stoffel, O. Zierenberg, B. Tungal, and E. Schreiber, 13-C Nuclear magnetic resonance spectroscopic evidence for hydrophobic lipid-protein interactions in human high density lipoproteins, Proc. Natl. Acad. Sci. USA 71: 3696 (1974).CrossRefGoogle Scholar
  6. 6.
    G. Assmann and H. Schriewer, Biochemie der high density lipoproteine, Klin. Wochenschr. 58: 749 (1980).CrossRefGoogle Scholar
  7. 7.
    E. J. Schaefer and R. I. Levy, Composition and metabolism of high density lipoproteins, Prog. Biochem. Pharmacol. 15: 200 (1979).Google Scholar
  8. 8.
    E. J. Schaefer, S. Eisenberg, and R. I. Levy. Lipoprotein apoprotein metabolism, J. Lipid Res. 19: 667 (1978).Google Scholar
  9. 9.
    J. W. Gofman, W. Young, and R. Tandy, Ischemic heart disease, atherosclerosis and longevity, Circulation 34: 679 (1966).CrossRefGoogle Scholar
  10. 10.
    Israel study: S. Yaari, U. Goldbourt, S. Even-Zohar, H. N. Neufeld, Association of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10,000 men, Lancet 1: 1011 (1981).CrossRefGoogle Scholar
  11. 11.
    J. J. Barboriak, A. J. Anderson, A. A. Rimm, and J. F. King, High density lipoprotein cholesterol and coronary artery occlusion, Metabolism 28: 735 (1979).CrossRefGoogle Scholar
  12. 12.
    J. R. Milne, D. L. Stone, S. O. Banim, D. J. Galton, and R. S. O. Rees, High density lipoprotein and other risk factors for coronary artery disease assessed by angiography, Br. Med. J. 282: 1274 (1981).CrossRefGoogle Scholar
  13. 13.
    J. O. Swanson, G. Pierpont, and A. Adicoff, Serum high density lipoprotein cholesterol correlates with presence but not severity of coronary artery disease, Am. J. Med. 71: 235 (1981).CrossRefGoogle Scholar
  14. 14.
    D. R. Holmes Jr., L. R. Elveback, R. L. Frye, B. A. Kottke, and R. D. Ellefson, Association of risk factor variables and coronary artery disease documented with angiography, Circulation 63: 293 (1981).CrossRefGoogle Scholar
  15. 15.
    G. Assmann, H. Funke, and H. Schriewer, The relationship of HDL-apolipoprotein A-I and HDL-cholesterol to risk factors of coronary heart disease. Initial results of the prospective epidemiological study in company employees in Westfalia, J. Clin. Chem. Clin. Biochem. 20: 287 (1982).Google Scholar
  16. 16.
    G. M. Kostner, P. Avogaro, G. Bittolo-Bon, G. Cazzalato, and G. B. Quinci, Determination of high-density lipoproteins: screening methods compared, Clin. Chem. 25: 939 (1979).Google Scholar
  17. 17.
    P. N. Herbert and L. D. Henderson, Plasma-triglycerides do not regulate high density lipoprotein concentration, Lancet 1: 1368 (1979).CrossRefGoogle Scholar
  18. 18.
    P. Schwandt, Die Apolipoproteine, Klin. Wochenschr. 60: 637 (1982).CrossRefGoogle Scholar
  19. 19.
    P. Avogaro, G. Bittolo-Bon, G. Cazzaloto, and E. Rorai, Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction, Arteriosclerosis 37: 69 (1980).CrossRefGoogle Scholar
  20. 20.
    G. DeBacker, M. Rosseneu, and J. P. Deslypere, Discriminative value of lipids and apoproteins in coronary heart disease, Atherosclerosis 42: 197 (1982).CrossRefGoogle Scholar
  21. 21.
    R. G. Kladetzky, G. Assmann, S. Walgenbach, P. Tauchert, and H.-D. Helb, Lipid and apoprotein values in coronary angiography patients, Artery 7: 191 (1980).Google Scholar
  22. 22.
    J. J. Maciejko, D. R. Holmes, B. A. Kottke, A. R. Zinsmeister, D. M. Dinh, and S. Y. T. Mao, Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease, N. Engl. J. Med. 309: 385 (1983).CrossRefGoogle Scholar
  23. 23.
    N. E. Miller, HDL-cholesterol, tissue cholesterol and coronary atherosclerosis. Epidemiological correlations, in “Atherosclerosis V: Proceedings of the 5th International Symposium,” A. M. Gotto Jr., L. C. Smith, and B. Allen, eds., Springer, New York (1980).Google Scholar
  24. 24.
    N. E. Miller, F. Hammett, S. Saltissi, S. Rao, H. Van Zeller, J. Coltart, and B. Lewis, Regulation of angiographically defined artery disease to plasma lipoprotein subfraction and apolipoproteins, Br. Med. J. 282: 1741 (1981).CrossRefGoogle Scholar
  25. 25.
    H. Schriewer, H. Schulte, and G. Assmann, HDL phosphatidyl choline and risk factors of coronary heart disease. Prospective epidemiological study of company employees of Westfalia, (manuscript submitted).Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Gerd Assmann
    • 1
  • Hilko Schriewer
    • 1
  1. 1.ZentrallaboratoriumUniversity of MünsterMünsterWest Germany

Personalised recommendations